MRI and biomechanics multidimensional data analysis reveals R(2) -R(1ρ) as an early predictor of cartilage lesion progression in knee osteoarthritis

MRI和生物力学多维数据分析揭示R(2) -R(1ρ)是膝骨关节炎软骨损伤进展的早期预测因子

阅读:1

Abstract

PURPOSE: To couple quantitative compositional MRI, gait analysis, and machine learning multidimensional data analysis to study osteoarthritis (OA). OA is a multifactorial disorder accompanied by biochemical and morphological changes in the articular cartilage, modulated by skeletal biomechanics and gait. While we can now acquire detailed information about the knee joint structure and function, we are not yet able to leverage the multifactorial factors for diagnosis and disease management of knee OA. MATERIALS AND METHODS: We mapped 178 subjects in a multidimensional space integrating: demographic, clinical information, gait kinematics and kinetics, cartilage compositional T(1ρ) and T(2) and R(2) -R(1ρ) (1/T(2) -1/T(1ρ) ) acquired at 3T and whole-organ magnetic resonance imaging score morphological grading. Topological data analysis (TDA) and Kolmogorov-Smirnov test were adopted for data integration, analysis, and hypothesis generation. Regression models were used for hypothesis testing. RESULTS: The results of the TDA showed a network composed of three main patient subpopulations, thus potentially identifying new phenotypes. T(2) and T(1ρ) values (T(2) lateral femur P = 1.45*10(-8) , T(1ρ) medial tibia P = 1.05*10(-5) ), the presence of femoral cartilage defects (P = 0.0013), lesions in the meniscus body (P = 0.0035), and race (P = 2.44*10(-4) ) were key markers in the subpopulation classification. Within one of the subpopulations we observed an association between the composite metric R(2) -R(1ρ) and the longitudinal progression of cartilage lesions. CONCLUSION: The analysis presented demonstrates some of the complex multitissue biochemical and biomechanical interactions that define joint degeneration and OA using a multidimensional approach, and potentially indicates that R(2) -R(1ρ) may be an imaging biomarker for early OA. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:78-90.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。